Top

FDA approves device to treat obsessive-compulsive disorder

The Food and Drug Administration has cleared a device that uses magnetic fields to stimulate nerve cells in the brain for the treatment of a common mental illness.

The procedure, called transcranial magnetic stimulation, was approved by the FDA as a treatment for major depression in 2008. The regulatory agency subsequently expanded the use to include TMS for treating pain associated with certain migraine headaches in 2013.

Now, the FDA has decided to permit the marketing of the Deep Transcranial Magnetic Stimulation System from Israeli vendor Brainsway for obsessive-compulsive disorder (OCD), based on the agency’s review of data from a randomized, multi-center study of 100 patients.

Read More on Health Data Management